Sabra Health Care REIT Announces Pricing of $100 Million Senior Notes Add-On Offering by Certain of Its Subsidiaries

Sabra Health Care REIT, Inc

today announced that certain subsidiaries of Sabra have agreed to sell $100 million aggregate principal amount of 8.125% senior notes due 2018 at a price of 106.000% plus accrued interest from May 1, 2012 in a private placement to "qualified institutional buyers" as defined in Rule 144A under the Securities Act of 1933, as amended, and outside the United States in reliance on Regulation S under the Securities Act. The sale of the Notes is expected to close on July 26, 2012. The Notes will be fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by Sabra and certain of Sabra's other existing and, subject to certain exceptions, future material subsidiaries. Sabra intends to use the net proceeds from the offering to repay the $42.5 million outstanding on its amended secured revolving credit facility, and the remaining proceeds to fund possible future acquisitions or for general corporate purposes.